Clinical Trials Browser

OTHER × LY-2157299 × Gastrointestinal × Clear all

NCT02688712 2026-04-13

ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Rectal Neoplasms

NCT05700656 2024-07-22

Galunisertib Combined With Capecitabine in Advanced CRC With PM

Phase 1/2 Recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT03470350 2019-07-24

EORTC1615

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Cancer Metastatic